Yang Zhao
Questioner · DISC type cYang Zhao is a Senior Principal Scientist at Boehringer Ingelheims Cancer Immunology Therapeutic Area, with a Ph. D. from the University of Michigan. He has a demonstrated history of leading drug discovery and early-phase development in oncology and immunology since 2007 at companies like Janssen and Eli Lilly.
Based on his shared content, Yang is deeply immersed in scientific advancement, frequently posting about cutting-edge research like CRISPR screens, cellular biology, and new therapeutic modalities. He appears driven by a problem-solving mindset, stating that being "solution oriented is the key, " and is keen on developing new talent.
He has served as a co-lead for the Clinical Development Teams for major drugs Simponi and Remicade.
Read the full overview →How Yang shows up
They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. They are more likely than others to negotiate on pricing and terms. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.
Topics Yang cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other Boehringer Ingelheim Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.